Over a billion people across tropical and subtropical regions worldwide grapple with the severe heal...
For June 2023, we draw your attention to the Endothelin A Receptor (ETAR) as the 'Clovertex Drug Tar...
In our previous exploration of IoT in cryo-EM, we illuminated how technology could democratize the f...
From the trenches of World War I to the ongoing battle against obesity, the story of UCP1 is as capt...
Whenever I hear about Internet of Things (IoT), I think of smart fridges that have been touted as th...
Introducing the Hottest Tweets in SBDD sponsored by MiTeGen, your curated source of recent tweets fo...
Historically, cystic fibrosis (CF) has been among the most gruesome genetic diseases, often seen as ...
For May 2023, we're spotlighting the Glucagon-Like Peptide-2 Receptor (GLP2R) as the 'Clovertex Drug...
Engaging in conversations with students, postdocs, and cryo-EM facility managers, I'm frequently ask...
In the fast-paced world of cryo-EM methods, remarkable advancements can occasionally go unnoticed am...